HCA Healthcare, Inc. (NYSE:HCA) Expected to Post Quarterly Sales of $14.88 Billion

Wall Street brokerages expect HCA Healthcare, Inc. (NYSE:HCAGet Rating) to report $14.88 billion in sales for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for HCA Healthcare’s earnings. The lowest sales estimate is $14.63 billion and the highest is $15.08 billion. HCA Healthcare reported sales of $14.44 billion in the same quarter last year, which would suggest a positive year over year growth rate of 3%. The business is scheduled to report its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that HCA Healthcare will report full-year sales of $60.91 billion for the current year, with estimates ranging from $60.46 billion to $61.45 billion. For the next year, analysts forecast that the firm will post sales of $64.03 billion, with estimates ranging from $63.56 billion to $64.73 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of analysts that that provide coverage for HCA Healthcare.

HCA Healthcare (NYSE:HCAGet Rating) last released its earnings results on Friday, April 22nd. The company reported $4.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.25 by ($0.13). The firm had revenue of $14.95 billion during the quarter, compared to analysts’ expectations of $14.72 billion. HCA Healthcare had a net margin of 11.40% and a return on equity of 405.72%. HCA Healthcare’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter last year, the company posted $4.14 earnings per share.

Several equities analysts recently commented on the stock. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, April 25th. Raymond James reduced their target price on HCA Healthcare from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Tuesday, April 26th. Cowen decreased their target price on HCA Healthcare from $265.00 to $241.00 in a report on Monday, April 25th. Citigroup decreased their price objective on shares of HCA Healthcare from $277.00 to $254.00 and set a “buy” rating for the company in a research note on Monday, April 25th. Finally, Credit Suisse Group decreased their price target on shares of HCA Healthcare from $296.00 to $260.00 and set an “outperform” rating for the company in a research report on Monday, April 25th. Six analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $261.38.

In related news, Director Andrea B. Smith purchased 1,160 shares of HCA Healthcare stock in a transaction dated Thursday, April 28th. The stock was bought at an average cost of $213.63 per share, with a total value of $247,810.80. Following the purchase, the director now owns 2,239 shares in the company, valued at approximately $478,317.57. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Joseph A. Sowell III sold 11,522 shares of the company’s stock in a transaction that occurred on Friday, March 11th. The stock was sold at an average price of $269.00, for a total value of $3,099,418.00. The disclosure for this sale can be found here. In the last three months, insiders have bought 91,370 shares of company stock valued at $19,373,375 and have sold 14,380 shares valued at $3,723,203. Insiders own 1.50% of the company’s stock.

A number of institutional investors have recently modified their holdings of the business. Vanguard Group Inc. grew its stake in shares of HCA Healthcare by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 19,113,498 shares of the company’s stock worth $4,790,225,000 after purchasing an additional 181,855 shares during the last quarter. BlackRock Inc. lifted its position in shares of HCA Healthcare by 5.6% during the 1st quarter. BlackRock Inc. now owns 17,302,042 shares of the company’s stock valued at $4,336,237,000 after acquiring an additional 925,010 shares during the last quarter. Wellington Management Group LLP raised its position in shares of HCA Healthcare by 4.1% during the first quarter. Wellington Management Group LLP now owns 14,315,204 shares of the company’s stock worth $3,587,676,000 after purchasing an additional 562,876 shares during the period. Sanders Capital LLC boosted its position in shares of HCA Healthcare by 3.2% in the 1st quarter. Sanders Capital LLC now owns 9,746,360 shares of the company’s stock valued at $2,652,853,000 after purchasing an additional 298,323 shares during the period. Finally, Invesco Ltd. lifted its stake in HCA Healthcare by 6.0% during the first quarter. Invesco Ltd. now owns 4,191,730 shares of the company’s stock valued at $1,050,530,000 after buying an additional 236,488 shares in the last quarter. Hedge funds and other institutional investors own 67.87% of the company’s stock.

Shares of NYSE:HCA opened at $205.04 on Tuesday. HCA Healthcare has a 12-month low of $198.69 and a 12-month high of $279.02. The stock’s 50-day moving average price is $239.62 and its two-hundred day moving average price is $244.20. The company has a current ratio of 1.43, a quick ratio of 1.24 and a debt-to-equity ratio of 87.46. The firm has a market cap of $60.59 billion, a price-to-earnings ratio of 9.65, a PEG ratio of 1.30 and a beta of 1.61.

HCA Healthcare declared that its board has approved a stock buyback plan on Thursday, January 27th that allows the company to repurchase $8.00 billion in shares. This repurchase authorization allows the company to repurchase up to 10.9% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board believes its stock is undervalued.

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 30th. Stockholders of record on Thursday, June 16th will be paid a $0.56 dividend. The ex-dividend date of this dividend is Wednesday, June 15th. This represents a $2.24 dividend on an annualized basis and a dividend yield of 1.09%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.54%.

About HCA Healthcare (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.